Transcranial Doppler Monitoring for Brain Injury
Trial Summary
The trial information does not specify whether you need to stop taking your current medications.
Research shows that Transcranial Doppler (TCD) can help predict neurological outcomes and detect patients at risk of worsening brain injury, which suggests it may be useful in managing brain injuries by providing early warning signs.
12345Transcranial Doppler (TCD) is generally considered safe for humans as it is a non-invasive method used to monitor blood flow in the brain. Studies have used TCD in various settings, including during physical stress and after head injuries, without reporting harmful effects.
36789Transcranial Doppler (TCD) is unique because it uses ultrasound to measure blood flow in the brain, helping to monitor and predict changes in brain pressure and blood flow after a brain injury. Unlike other treatments, it is non-invasive, meaning it doesn't require surgery or entering the body, and can be used repeatedly to track a patient's condition over time.
123510Eligibility Criteria
This trial is for children and teens (28 days to 18 years old) who have had a serious brain injury like trauma or stroke within the last day. They must be in the PICU at Children's Medical Center Dallas with an arterial line already placed for care, and some may also have ICP monitoring.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Acute Monitoring
Non-invasive monitoring of cerebral autoregulation using TCD and NIRS over the first 7-10 days post-injury
Follow-up
Participants are monitored for neurologic outcomes using GOSEP and PEDI-CAT at hospital discharge, 3, 6, and 12 months post-injury